Literature DB >> 24819072

N-Acetylcysteine: an old drug, a new insight, a potentially effective treatment for thrombotic thrombocytopenic purpura.

James N George1, José A López, Barbara A Konkle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24819072     DOI： 10.1111/trf.12561

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

Review 1.  How I treat refractory thrombotic thrombocytopenic purpura.

Authors:  Farzana A Sayani; Charles S Abrams
Journal:  Blood       Date:  2015-03-17       Impact factor: 22.113

2.  Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.

Authors:  Sara Martinez de Lizarrondo; Clément Gakuba; Bradley A Herbig; Yohann Repessé; Carine Ali; Cécile V Denis; Peter J Lenting; Emmanuel Touzé; Scott L Diamond; Denis Vivien; Maxime Gauberti
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

Review 3.  The role of von Willebrand factor in thrombotic microangiopathy.

Authors:  Damien G Noone; Magdalena Riedl; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2017-07-26       Impact factor: 3.714

4.  Treatment of severe, refractory and rapidly evolving thrombotic thrombocytopenic purpura.

Authors:  Rey R Acedillo; Mayur Govind; Abdullah Kashgary; William F Clark
Journal:  BMJ Case Rep       Date:  2016-06-09

5.  Anti-thrombotic strategies for microfluidic blood processing.

Authors:  Keith H K Wong; Jon F Edd; Shannon N Tessier; Will D Moyo; Baris R Mutlu; Lauren D Bookstaver; Kathleen L Miller; Stefan Herrara; Shannon L Stott; Mehmet Toner
Journal:  Lab Chip       Date:  2018-07-24       Impact factor: 6.799
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.